The House Oversight Committee will hold a hearing Thursday (Dec. 9) on findings from the ninth and final report of its three-year investigation into drug price-setting practices, Oversight Chair Carolyn Maloney (D-NY) announced Friday. The hearing keeps attention on industry drug-pricing practices as Senate Democrats discuss possible changes to the drug price measures in their Build Back Better Act. Although Democrats agreed to the drug measures , some of the language is at risk of being altered or stripped due...